Health Technology Assessment

Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer

Date of publication: 
Thursday, April 18, 2013

HTA on the monitoring of women under 50 years of age at a higher risk of breast cancer due to a genetic predisposition or a strong family history.

Health technology assessment of a national deep brain stimulation service in Ireland

Date of publication: 
Wednesday, November 7, 2012

The results of a health technology assessment (HTA) of a national deep brain stimulation (DBS) programme for adults with movement disorders have been published by the Authority. This HTA shows that the current system where patients are routinely referred to the UK for treatment costs less than a proposed service provided nationally.

Economic Evaluation of Repeat Universal Antenatal Screening for HIV in the Third Trimester of Pregnancy

Date of publication: 
Monday, April 23, 2012

This report contains HIQA’s advice to the HSE on whether a change in the existing Irish guidelines for the management of HIV-1 in pregnancy is warranted.

Health technology assessment of robot-assisted surgery in selected surgical procedures

Date of publication: 
Wednesday, January 11, 2012

A health technology assessment of robot-assisted keyhole surgery has concluded that while the benefits to patients in certain surgical procedures are evident, the cost of its introduction would be significant.

Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland

Date of publication: 
Thursday, November 24, 2011

These Guidelines set out to evaluate the clinical effectiveness of health technologies for the Irish health service. They provide direction on how to measure the ability of a healthcare technology to make a significant difference to a patient’s health status.

Draft Guidelines for Evaluating the Clinical Effectiveness of Health Technologies in Ireland

Date of publication: 
Thursday, September 1, 2011

The purpose of these guidelines is to assist those conducting or using HTA in Ireland. They also inform health technology suppliers who prepare applications for reimbursement. These draft guidelines are now available for consultation.

A health technology assessment of prion filtration of red cell concentrates to reduce the risk of variant Creutzfeldt-Jakob disease transmission in Ireland

Date of publication: 
Wednesday, July 27, 2011

This health technology assessment (HTA) examined the potential for a new technology, prion filtration, to reduce the risk of variant Creutzfeldt-Jakob disease (vCJD) transmission from the transfusion of red cell concentrates (RCC) in Ireland.

Report of the Evaluation of the use of resources in the national population-based cancer screening programmes and associated services

Date of publication: 
Friday, January 15, 2010

Colorectal cancer is the second most frequently diagnosed cancer in men and women in this country. During the time period 2002 to 2005, an average of 2,040 new cases of colorectal cancer were diagnosed each year. During the same time period, an average of 925 people died each year from the disease.

In June 2009, the Minister for Health and Children requested the Authority to:

Guidelines for the Budget Impact Analysis of Health Technologies in Ireland

Date of publication: 
Tuesday, November 23, 2010

This document, Guidelines for Budget Impact Analysis of Health Technologies in Ireland is a complementary document to the Guidelines for Economic Evaluation of Health Technologies in Ireland (2010). They are limited to methodological guidance on the conduct of budget impact analysis and are intended to promote best practice in budget impact analysis (BIA). They will be reviewed and revised as necessary. The purpose of these BIA guidelines is to assist those conducting or using BIA as part of HTA in Ireland.

Syndicate content